Clinical Diagnosis and Management of Breast Cancer

Overview

Journal J Nucl Med

Specialty Nuclear Medicine

Date 2016 Feb 3

PMID 26834110

Citations 228

Authors

Elizabeth S McDonald

Amy S Clark

Julia Tchou

Paul Zhang

Gary M Freedman

Affiliations

Soon will be listed here.

Abstract

The diagnosis and management of breast cancer are undergoing a paradigm shift from a one-size-fits-all approach to an era of personalized medicine. Sophisticated diagnostics, including molecular imaging and genomic expression profiles, enable improved tumor characterization. These diagnostics, combined with newer surgical techniques and radiation therapies, result in a collaborative multidisciplinary approach to minimizing recurrence and reducing treatment-associated morbidity. This article reviews the diagnosis and treatment of breast cancer, including screening, staging, and multidisciplinary management.

Citing Articles

Identification of candidate biomarkers correlated with the pathogenesis of breast cancer patients.

Yu S, Wang C, Ouyang J, Luo T, Zeng F, Zhang Y Sci Rep. 2025; 15(1):8770.

PMID: 40082607 PMC: 11906855. DOI: 10.1038/s41598-025-93208-w.

Post-marketing safety of elacestrant in breast cancer: a pharmacovigilance investigation using the FDA adverse event reporting system.

Fan Z, Xu Y, Guo S, Song B BMC Pharmacol Toxicol. 2025; 26(1):56.

PMID: 40069893 PMC: 11895172. DOI: 10.1186/s40360-025-00887-2.

Replication factor C4, which is regulated by insulin-like growth factor 2 mRNA binding protein 2, enhances the radioresistance of breast cancer by promoting the stemness of tumor cells.

Zhu X, Li P, Qu H, Ai X, Zhao Z, He J Hum Cell. 2025; 38(3):65.

PMID: 40053279 DOI: 10.1007/s13577-025-01197-9.

Axillary lymph node metastasis in breast cancer: from historical axillary surgery to updated advances in the preoperative diagnosis and axillary management.

Wu T, Long Q, Zeng L, Zhu J, Gao H, Deng Y BMC Surg. 2025; 25(1):81.

PMID: 40016717 PMC: 11869450. DOI: 10.1186/s12893-025-02802-2.

Machine learning for predicting neoadjuvant chemotherapy effectiveness using ultrasound radiomics features and routine clinical data of patients with breast cancer.

Zhou P, Qian H, Zhu P, Ben J, Chen G, Chen Q Front Oncol. 2025; 14:1485681.

PMID: 39927116 PMC: 11803464. DOI: 10.3389/fonc.2024.1485681.